Treatment Benefit Associating with Non-Anthracycline Chemotherapy in Extranodal NK/T-Cell Lymphoma, Nasal Type: A Multicenter Study from the China Lymphoma Collaborative Group (CLCG)
第一作者机构:[1]CAMS, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China[2]PUMC, Beijing, Peoples R China[3]CAMS, Ctr Canc Precis Med, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Yang Y.,Qi S.,Liu W. P.,et al.Treatment Benefit Associating with Non-Anthracycline Chemotherapy in Extranodal NK/T-Cell Lymphoma, Nasal Type: A Multicenter Study from the China Lymphoma Collaborative Group (CLCG)[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2019,105(1):S247-S248.doi:10.1016/j.ijrobp.2019.06.366.
APA:
Yang, Y.,Qi, S.,Liu, W. P.,Su, H.,Wang, Y....&Li, Y. X..(2019).Treatment Benefit Associating with Non-Anthracycline Chemotherapy in Extranodal NK/T-Cell Lymphoma, Nasal Type: A Multicenter Study from the China Lymphoma Collaborative Group (CLCG).INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,105,(1)
MLA:
Yang, Y.,et al."Treatment Benefit Associating with Non-Anthracycline Chemotherapy in Extranodal NK/T-Cell Lymphoma, Nasal Type: A Multicenter Study from the China Lymphoma Collaborative Group (CLCG)".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 105..1(2019):S247-S248